SOR-104

N/A

Report date: 2024/06/18 17:34:44

Base Information

Drug NameSOR-104
Drug Alias NameSOR-104SOR104
ClassificationBiologics
Mechanisms of ActionAnti-Interleukin-7 receptor subunit alphaAnti-Thymic stromal lymphopoietin
TargetsInterleukin-7 receptor subunit alphaThymic stromal lymphopoietin
Therapy Area/IndicationsAsthmaGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSorriso Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSorriso Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAsthmaGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A